PEPID Funding: How Much Did They Raise & Key Investors

How Much Did PEPID Raise?
Funding & Key Investors

PEPID, a long-standing pillar in the medical informatics sector, has successfully secured significant capital to bolster its enterprise-level operations. The firm, which has accumulated a total funding amount of $656K, recently finalized a major strategic investment totaling $306K. This infusion of capital underscores the company's enduring relevance in the digital health landscape and its capacity to attract substantial debt financing to support its ongoing mission of optimizing clinical workflows.

The trajectory of PEPID reflects a deliberate growth strategy, moving from its foundational roots in 1994 to its current status as a critical infrastructure provider for healthcare systems. By leveraging this recent financing, the organization is well-positioned to scale its technical capabilities and expand its reach within the competitive medical reference resource market.

What is PEPID?

PEPID

Software

Healthcare Software

PEPID operates as a premier provider of clinical decision support tools and comprehensive medical reference resources. The platform is engineered to serve a diverse spectrum of healthcare professionals, ranging from emergency physicians and primary care practitioners to nurse practitioners and medical students. By integrating drug information and peer-reviewed medical content directly into the clinical workflow, PEPID facilitates more accurate and efficient decision-making at the point of care.

The company's market position is defined by its commitment to evidence-based medicine and its ability to integrate seamlessly into hospital information systems. As healthcare institutions increasingly prioritize digital transformation to improve patient outcomes, PEPID remains a vital partner, offering the essential knowledge required to navigate complex clinical scenarios with precision and speed.

How much funding has PEPID raised?

PEPID has raised a total of $656K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$306K

Debt (2020): $350K with participation from PPP

Debt (2021): $306K led by PPP

Key Investors in PEPID

PPP

Public-Private Partnership

What's next for PEPID?

With the recent capital injection, PEPID is poised to accelerate its product development roadmap and enhance its enterprise-grade software offerings. The strategic focus will likely center on deepening the integration of its medical content within electronic health record systems and expanding its footprint in educational and clinical environments. As the demand for reliable, real-time clinical intelligence continues to rise, PEPID is strategically aligned to capitalize on the shift toward data-driven healthcare delivery.

The company's ability to secure major debt financing suggests a stable financial outlook and a clear path toward long-term sustainability. Future initiatives will likely prioritize the refinement of its peer-reviewed content delivery mechanisms, ensuring that healthcare providers remain equipped with the most current and actionable information available in the industry.

See full PEPID company page

See More Financial Insights